ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 441 filers reported holding ASTRAZENECA PLC in Q3 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,291,904 | +4.4% | 16,565 | -9.3% | 0.02% | 0.0% |
Q1 2024 | $1,237,657 | +10.9% | 18,268 | +10.2% | 0.02% | 0.0% |
Q4 2023 | $1,116,259 | +14.3% | 16,574 | +14.9% | 0.02% | +5.0% |
Q3 2023 | $976,793 | +43.6% | 14,424 | +51.8% | 0.02% | +42.9% |
Q2 2023 | $680,273 | -6.0% | 9,505 | -8.8% | 0.01% | -6.7% |
Q1 2023 | $723,322 | -4.6% | 10,421 | -6.8% | 0.02% | -11.8% |
Q4 2022 | $758,411 | +25.6% | 11,186 | +1.5% | 0.02% | +21.4% |
Q3 2022 | $604,000 | -38.4% | 11,020 | -25.8% | 0.01% | -33.3% |
Q2 2022 | $980,000 | +17.2% | 14,844 | +17.8% | 0.02% | +40.0% |
Q1 2022 | $836,000 | +15.8% | 12,602 | +1.6% | 0.02% | +15.4% |
Q4 2021 | $722,000 | -0.7% | 12,399 | +2.4% | 0.01% | -7.1% |
Q3 2021 | $727,000 | -16.6% | 12,104 | -16.8% | 0.01% | -12.5% |
Q2 2021 | $872,000 | -29.2% | 14,546 | -41.3% | 0.02% | -36.0% |
Q1 2021 | $1,232,000 | -0.4% | 24,785 | +0.2% | 0.02% | -3.8% |
Q4 2020 | $1,237,000 | -19.7% | 24,745 | -12.1% | 0.03% | -33.3% |
Q3 2020 | $1,541,000 | +100.7% | 28,139 | +93.6% | 0.04% | +95.0% |
Q2 2020 | $768,000 | +108.7% | 14,537 | +76.2% | 0.02% | +81.8% |
Q1 2020 | $368,000 | -69.8% | 8,252 | -66.3% | 0.01% | -63.3% |
Q4 2019 | $1,220,000 | +2.9% | 24,469 | -8.1% | 0.03% | -6.2% |
Q3 2019 | $1,186,000 | +6.6% | 26,615 | -1.3% | 0.03% | +6.7% |
Q2 2019 | $1,113,000 | -1.7% | 26,953 | -3.8% | 0.03% | 0.0% |
Q1 2019 | $1,132,000 | +8.1% | 28,007 | +1.6% | 0.03% | -9.1% |
Q4 2018 | $1,047,000 | -28.3% | 27,561 | -25.3% | 0.03% | -10.8% |
Q3 2018 | $1,460,000 | +10.4% | 36,906 | -1.9% | 0.04% | +2.8% |
Q2 2018 | $1,322,000 | +4.1% | 37,631 | +3.6% | 0.04% | +9.1% |
Q1 2018 | $1,270,000 | +24.3% | 36,338 | +23.3% | 0.03% | +26.9% |
Q4 2017 | $1,022,000 | +85.8% | 29,482 | +81.8% | 0.03% | +73.3% |
Q3 2017 | $550,000 | +17.0% | 16,214 | +17.5% | 0.02% | +15.4% |
Q2 2017 | $470,000 | -20.6% | 13,803 | -27.4% | 0.01% | -23.5% |
Q1 2017 | $592,000 | +121.7% | 19,006 | +94.9% | 0.02% | +112.5% |
Q4 2016 | $267,000 | -79.4% | 9,753 | -75.3% | 0.01% | -78.9% |
Q3 2016 | $1,297,000 | +43.2% | 39,471 | +31.7% | 0.04% | +40.7% |
Q2 2016 | $906,000 | +126.5% | 29,981 | +110.7% | 0.03% | +125.0% |
Q1 2016 | $400,000 | -13.4% | 14,227 | +4.7% | 0.01% | -14.3% |
Q4 2015 | $462,000 | -5.9% | 13,593 | -11.8% | 0.01% | -6.7% |
Q3 2015 | $491,000 | +46.1% | 15,417 | +192.8% | 0.02% | +66.7% |
Q2 2015 | $336,000 | -10.6% | 5,266 | -4.0% | 0.01% | -10.0% |
Q1 2015 | $376,000 | +3.6% | 5,486 | +6.3% | 0.01% | 0.0% |
Q4 2014 | $363,000 | -8.1% | 5,159 | -6.6% | 0.01% | -16.7% |
Q3 2014 | $395,000 | -75.2% | 5,525 | -74.2% | 0.01% | -75.0% |
Q2 2014 | $1,594,000 | -20.7% | 21,443 | -30.8% | 0.05% | -20.0% |
Q1 2014 | $2,011,000 | -4.5% | 30,994 | -12.6% | 0.06% | -10.4% |
Q4 2013 | $2,105,000 | -11.6% | 35,454 | -22.7% | 0.07% | -20.2% |
Q3 2013 | $2,382,000 | +20.7% | 45,862 | +9.9% | 0.08% | +10.5% |
Q2 2013 | $1,973,000 | – | 41,722 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |